BOSTON and LONDON, Sept. 21, 2023 (GLOBE NEWSWIRE) Akari Therapeutics, Plc (NASDAQ:AKTX) ("Akari" or the "Company"), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory
Akari Therapeutics Plc: Akari Therapeutics Appoints Industry Veteran Wa el Hashad to Board of Directors finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt as to what action you should take, you are recommended to seek your own financial advice. | June 6, 2023
In March 2023, Akari Therapeutics, Plc sold to certain accredited and institutional investors, led by existing investors and certain of the Company s officers and members of its Board of. | May 3, 2023